Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
184
184 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- DNA VaccinePhase 22 trials
NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)
- DS-8201Phase 22 trials
Sichuan Baili Pharmaceutical Co., Ltd. · Breast Cancer, Advanced Solid Tumor
- endoxifenPhase 22 trials
Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer
- FWD1802Phase 22 trials
Forward Pharmaceuticals Co., Ltd. · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV
- GI-102Phase 22 trials
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)
- HRS-1358Phase 22 trials
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors
- HRS-6208Phase 22 trials
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer of Adults, Prostate Cancer
- HRS-9813Phase 22 trials
Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors, IPF and PPF
- LS301-ITPhase 22 trials
Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS
- MRT-2359Phase 22 trials
Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC
- PF-07104091ovarian, SCLCPhase 22 trials
Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer
- QLC1401Phase 22 trials
Qilu Pharmaceutical Co., Ltd. · Advanced Breast Cancer, Advanced ER+/HER2- Breast Cancer
- SapanisertibFTH-003, MLN0128Phase 22 trials
Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer
- SelicrelumabPhase 22 trials
Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma
- SerabelisibFTH-001, MLN1117Phase 22 trials
Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer
- SKB103Phase 22 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors, Breast Cancer
- SSGJ-612HER2-targeted antibodyPhase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer
- STAR0602InvikafuspPhase 22 trials
Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors
- SYH2051Phase 22 trials
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Breast Cancer
- TYK-00540Phase 22 trials
TYK Medicines, Inc · mCRPC, HR-positive, HER2-negative Advanced Breast Cancer
- YL202 should be intravenously infusedPhase 22 trials
MediLink Therapeutics (Suzhou) Co., Ltd. · NSCLC, Breast Cancer, HNSCC
- ACE-86225106Phase 21 trial
Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation
- AMXI-5001Phase 21 trial
AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer
- ARX788Phase 21 trial
Ambrx, Inc. · HER2 Positive Metastatic Breast Cancer
- ATX-295Phase 21 trial
Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer
- AVZO-023Phase 21 trial
Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- AZD8421Phase 21 trial
AstraZeneca · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)
- BB-1701Phase 21 trial
Eisai · Breast Cancer
- BCD-236Phase 21 trial
Biocad · Triple Negative Breast Cancer
- BL0175Phase 21 trial
Shanghai Best-Link Bioscience, LLC · Breast Cancer (Locally Advanced or Metastatic)
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- CFI-402257Phase 21 trial
Treadwell Therapeutics, Inc · Advanced Solid Tumor, Breast Cancer
- CRG-150Phase 21 trial
CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer
- CYT-0851Phase 21 trial
Cyteir Therapeutics, Inc. · Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma
- ECI830Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
- EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial
NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- EP0062Phase 21 trial
Ellipses Pharma · Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
- ETX-19477Phase 21 trial
858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer
- ETX-636Phase 21 trial
Ensem Therapeutics · Advanced Solid Tumors, Advanced Breast Cancer
- EvexomostatSDX-7320Phase 21 trial
SynDevRx, Inc. · HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
- FluvustatPhase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer
- GB268Phase 21 trial
Eddingpharm (Zhuhai) Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic)
- GDC-4198RGT-419B, RO7840734Phase 21 trial
Roche (Genentech) · Breast Cancer
- GM103Phase 21 trial
GeneMedicine Co., Ltd. · Head and Neck Cancer, Malignant Melanoma, Colorectal Cancer
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- HP568Phase 21 trial
Hinova Pharmaceuticals Inc. · Breast Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.